Targeted Lipolysis is the precise, localized activation of the enzymatic pathway responsible for the breakdown of stored triglycerides within adipocytes, resulting in the release of free fatty acids and glycerol for energy use. In a clinical context, this term often refers to therapeutic strategies or specific physiological signals designed to preferentially mobilize fat from particular depots, especially those resistant to general caloric restriction. It is a critical component of body composition management and systemic energy debt reversal.
Origin
The term combines ‘lipolysis,’ derived from the Greek lipos (fat) and lysis (loosening or splitting), which is the biochemical process of fat breakdown, with ‘Targeted,’ emphasizing the selective and controlled nature of the intervention. This is a concept used in specialized metabolic and body composition optimization.
Mechanism
The mechanism involves the localized application of agents or signals that increase the concentration of cyclic AMP (cAMP) within specific adipocytes, thereby activating hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL). This process can be modulated by regional differences in adrenergic receptor density, where beta-adrenergic stimulation promotes lipolysis and alpha-adrenergic stimulation inhibits it. Effective targeted lipolysis requires overcoming the local regulatory resistance of the fat tissue to enhance adipose tissue access.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.